NCT06484738View on ClinicalTrials.gov

Spatially Resolved IBD: Spatial Transcriptomics of Inflammatory Bowel Disease (IBD)

Not yet recruitingOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
Patients With Histologically Confirmed CD Undergoing Intestinal Resection According to Standard of Care Due to Complicating DiseasePatients With Histologically Confirmed UC Undergoing Intestinal Resection According to Standard of Care Due to Complicating Disease
Interventions
OTHER

transcriptomic analysis

to use their biological samples from UC and CD patients, already stored at -80°C for transcriptomic analysis through STOmics Stereoseq

Trial Locations (2)

20132

Irccs Ospedale San Raffaele, Milan

Unknown

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
collaborator

BGI, China

OTHER

lead

IRCCS San Raffaele

OTHER